Showing results (321-330 of 1,787) with videos related to
Sort By:
Pageof 179
Hepatology Communications|December 12, 2025
The alternative splicing landscape of hepatocellular carcinoma and its potential for HCC detectionCourtney E Hershberger, Noah J Daniels, William M Patterson, et al.Hepatology Communications|December 13, 2024
Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver diseaseHiroshi Ishiba, Hideki Fujii, Yoshihiro Kamada, et al.Hepatology Communications|December 13, 2024
Key role of macrophages in the progression of hepatic fibrosisJinqiu Ran, Shengxia Yin, Rahma Issa, et al.Hepatology Communications|February 10, 2025
Loss of mitochondrial amidoxime-reducing component 1 (mARC1) prevents disease progression by reducing fibrosis in multiple mouse models of chronic liver diseaseErin S Coyne, Yilin Nie, Darwin Lee, et al.Hepatology Communications|February 3, 2025
Children with autoimmune hepatitis receiving standard-of-care therapy demonstrate long-term obesity and linear growth delayOr Steg Saban, Shannon M Vandriel, Syeda Aiman Fatima, et al.Hepatology Communications|January 29, 2025
Hepatocyte Rho-associated kinase signaling is required for mice to survive experimental porphyria-associated liver injuryJessica M Herrera, Yun Weng, Tyler J Lieberthal, et al.Hepatology Communications|February 26, 2025
Multiple features of cell-free mtDNA for predicting transarterial chemoembolization response in hepatocellular carcinomaMiao Dang, Siyuan Wang, Fan Peng, et al.Hepatology Communications|February 26, 2025
IL-8-NF-κB-ALDH1A1 loop promotes the progression of intrahepatic cholangiocarcinomaYinghui Song, Yufeng Li, Jia Zhou, et al.Hepatology Communications|March 13, 2025
EBV enhances immunotherapy sensitivity in intrahepatic cholangiocarcinoma through cGAS-STING pathway activationLingli Huang, Qian Zhong, Silan Huang, et al.Hepatology Communications|February 26, 2025
A novel KEAP1 inhibitor, tiliroside, activates NRF2 to protect against acetaminophen-induced oxidative stress and acute liver injuryFangfang Cai, Kaiqian Zhou, Peipei Wang, et al.Pageof 179